Argus II retinal prosthesis implantation with scleral flap and autogenous temporalis fascia as alternative patch graft material: a 4-year follow-up

Alexandre Matet,1,2 Nawel Amar,1,2 Saddek Mohand-Said,1–4 José-Alain Sahel,1–7 Pierre-Olivier Barale1,2 1INSERM and DHOS, CHNO des Quinze-Vingts, 2Sorbonne Universités, UPMC Univ Paris 6, Institut de la Vision, 3INSERM, 4CNRS, Paris, France; 5Institute of O...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Matet A, Amar N, Mohand-Said S, Sahel JA, Barale PO
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://doaj.org/article/a53650d5e5f14986bfe4dfb2f047aa69
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a53650d5e5f14986bfe4dfb2f047aa69
record_format dspace
spelling oai:doaj.org-article:a53650d5e5f14986bfe4dfb2f047aa692021-12-02T06:11:17ZArgus II retinal prosthesis implantation with scleral flap and autogenous temporalis fascia as alternative patch graft material: a 4-year follow-up1177-5483https://doaj.org/article/a53650d5e5f14986bfe4dfb2f047aa692016-08-01T00:00:00Zhttps://www.dovepress.com/argus-ii-retinal-prosthesis-implantation-with-scleral-flap-and-autogen-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Alexandre Matet,1,2 Nawel Amar,1,2 Saddek Mohand-Said,1–4 José-Alain Sahel,1–7 Pierre-Olivier Barale1,2 1INSERM and DHOS, CHNO des Quinze-Vingts, 2Sorbonne Universités, UPMC Univ Paris 6, Institut de la Vision, 3INSERM, 4CNRS, Paris, France; 5Institute of Ophthalmology, University College London, London, UK; 6Fondation Ophtalmologique Adolphe de Rothschild, 7Académie des Sciences, Institut de France, Paris, France Introduction: The Argus II retinal prosthesis is composed of an epiretinal electrode array positioned over the macula and connected to an extrascleral electronics case via a silicone cable, running through a sclerotomy. During implantation, the manufacturer recommends to cover the sclerotomy site with a patch of processed human pericardium to prevent postoperative hypotony and conjunctival erosion by the underlying electronics case. Due to biomedical regulations prohibiting the use of this material in France, we developed an alternative technique combining a scleral flap protecting the sclerotomy and an autogenous graft of superior temporalis fascia overlying the electronics case. Methods: The purpose of this study is to describe the 4-year outcomes of this modified procedure in three subjects who underwent Argus II Retinal Prosthesis System implantation. Clinical data consisting of intraocular pressure measurements and tolerance in terms of conjunctival erosion or inflammation were retrospectively assessed over a 4-year postoperative follow-up. Results: None of the three patients implanted with the modified technique developed ocular hypotony over 4 years. A normal, transient conjunctival inflammation occurred during the first postoperative month but conjunctival erosion was not observed in any of the three patients over 4 years. Four years after implantation, the autogenous temporalis fascia graft remained well tolerated and the retinal prosthesis was functional in all three patients. Conclusion: The combination of an autograft of superficial temporalis fascia and a scleral flap efficiently prevented leakage through the sclerotomy site, ocular hypotony, and conjunctival erosion by the extrascleral electronics case. This modified technique is suitable for the implantation of existing and forthcoming retinal prostheses. Superficial temporalis fascia may also be used as alternative to commercial tectonic tissues for scleral wound repair in clinical settings where they are not available. Keywords: visual prosthesis, retinitis pigmentosa, surgical procedure, conjunctiva, intraocular pressureMatet AAmar NMohand-Said SSahel JABarale PODove Medical Pressarticlevisual prosthesisautograftsurgical procedureconjunctivaintraocular pressureOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 10, Pp 1565-1571 (2016)
institution DOAJ
collection DOAJ
language EN
topic visual prosthesis
autograft
surgical procedure
conjunctiva
intraocular pressure
Ophthalmology
RE1-994
spellingShingle visual prosthesis
autograft
surgical procedure
conjunctiva
intraocular pressure
Ophthalmology
RE1-994
Matet A
Amar N
Mohand-Said S
Sahel JA
Barale PO
Argus II retinal prosthesis implantation with scleral flap and autogenous temporalis fascia as alternative patch graft material: a 4-year follow-up
description Alexandre Matet,1,2 Nawel Amar,1,2 Saddek Mohand-Said,1–4 José-Alain Sahel,1–7 Pierre-Olivier Barale1,2 1INSERM and DHOS, CHNO des Quinze-Vingts, 2Sorbonne Universités, UPMC Univ Paris 6, Institut de la Vision, 3INSERM, 4CNRS, Paris, France; 5Institute of Ophthalmology, University College London, London, UK; 6Fondation Ophtalmologique Adolphe de Rothschild, 7Académie des Sciences, Institut de France, Paris, France Introduction: The Argus II retinal prosthesis is composed of an epiretinal electrode array positioned over the macula and connected to an extrascleral electronics case via a silicone cable, running through a sclerotomy. During implantation, the manufacturer recommends to cover the sclerotomy site with a patch of processed human pericardium to prevent postoperative hypotony and conjunctival erosion by the underlying electronics case. Due to biomedical regulations prohibiting the use of this material in France, we developed an alternative technique combining a scleral flap protecting the sclerotomy and an autogenous graft of superior temporalis fascia overlying the electronics case. Methods: The purpose of this study is to describe the 4-year outcomes of this modified procedure in three subjects who underwent Argus II Retinal Prosthesis System implantation. Clinical data consisting of intraocular pressure measurements and tolerance in terms of conjunctival erosion or inflammation were retrospectively assessed over a 4-year postoperative follow-up. Results: None of the three patients implanted with the modified technique developed ocular hypotony over 4 years. A normal, transient conjunctival inflammation occurred during the first postoperative month but conjunctival erosion was not observed in any of the three patients over 4 years. Four years after implantation, the autogenous temporalis fascia graft remained well tolerated and the retinal prosthesis was functional in all three patients. Conclusion: The combination of an autograft of superficial temporalis fascia and a scleral flap efficiently prevented leakage through the sclerotomy site, ocular hypotony, and conjunctival erosion by the extrascleral electronics case. This modified technique is suitable for the implantation of existing and forthcoming retinal prostheses. Superficial temporalis fascia may also be used as alternative to commercial tectonic tissues for scleral wound repair in clinical settings where they are not available. Keywords: visual prosthesis, retinitis pigmentosa, surgical procedure, conjunctiva, intraocular pressure
format article
author Matet A
Amar N
Mohand-Said S
Sahel JA
Barale PO
author_facet Matet A
Amar N
Mohand-Said S
Sahel JA
Barale PO
author_sort Matet A
title Argus II retinal prosthesis implantation with scleral flap and autogenous temporalis fascia as alternative patch graft material: a 4-year follow-up
title_short Argus II retinal prosthesis implantation with scleral flap and autogenous temporalis fascia as alternative patch graft material: a 4-year follow-up
title_full Argus II retinal prosthesis implantation with scleral flap and autogenous temporalis fascia as alternative patch graft material: a 4-year follow-up
title_fullStr Argus II retinal prosthesis implantation with scleral flap and autogenous temporalis fascia as alternative patch graft material: a 4-year follow-up
title_full_unstemmed Argus II retinal prosthesis implantation with scleral flap and autogenous temporalis fascia as alternative patch graft material: a 4-year follow-up
title_sort argus ii retinal prosthesis implantation with scleral flap and autogenous temporalis fascia as alternative patch graft material: a 4-year follow-up
publisher Dove Medical Press
publishDate 2016
url https://doaj.org/article/a53650d5e5f14986bfe4dfb2f047aa69
work_keys_str_mv AT mateta argusiiretinalprosthesisimplantationwithscleralflapandautogenoustemporalisfasciaasalternativepatchgraftmateriala4yearfollowup
AT amarn argusiiretinalprosthesisimplantationwithscleralflapandautogenoustemporalisfasciaasalternativepatchgraftmateriala4yearfollowup
AT mohandsaids argusiiretinalprosthesisimplantationwithscleralflapandautogenoustemporalisfasciaasalternativepatchgraftmateriala4yearfollowup
AT sahelja argusiiretinalprosthesisimplantationwithscleralflapandautogenoustemporalisfasciaasalternativepatchgraftmateriala4yearfollowup
AT baralepo argusiiretinalprosthesisimplantationwithscleralflapandautogenoustemporalisfasciaasalternativepatchgraftmateriala4yearfollowup
_version_ 1718400067743776768